Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERE | Common Stock | Options Exercise | $20.6K | +5.87K | +296.62% | $3.50* | 7.85K | Dec 23, 2021 | Direct | F1, F2 |
transaction | CERE | Common Stock | Sale | -$206K | -5.87K | -74.79% | $35.00 | 1.98K | Dec 23, 2021 | Direct | F1, F3 |
transaction | CERE | Common Stock | Options Exercise | $14.4K | +4.13K | +208.43% | $3.50* | 6.11K | Dec 27, 2021 | Direct | F1 |
transaction | CERE | Common Stock | Sale | -$144K | -4.13K | -67.58% | $35.00 | 1.98K | Dec 27, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERE | Stock Option (Right to Buy) | Options Exercise | $0 | -5.87K | -1.54% | $0.00 | 375K | Dec 23, 2021 | Common Stock | 5.87K | $3.50 | Direct | F1, F4 |
transaction | CERE | Stock Option (Right to Buy) | Options Exercise | $0 | -4.13K | -1.1% | $0.00 | 371K | Dec 27, 2021 | Common Stock | 4.13K | $3.50 | Direct | F1, F4 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated October 8, 2021 adopted by the Reporting Person. |
F2 | Includes 1,980 shares acquired under the Issuer's Employee Stock Purchase Plan on May 28, 2021. |
F3 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | 25% of the shares subject to this option vested and became exercisable on April 8, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. |